Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice

Antonia S. Carrolla Brain and Mind Centre, Faculty of Medicine and Health, Translational Research Collective University of Sydney and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia;b Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKCorrespondence[email protected]
View further author information

Yousuf Razvic National Amyloidosis Centre, UCL Division of Medicine, Royal Free Hospital, London, UKView further author information

Luke O’Donnellb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information

Elena Velevad UK Dementia Research Institute at UCL, London, UKView further author information

Amanda Heslegraved UK Dementia Research Institute at UCL, London, UK;e Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UKView further author information

Henrik Zetterbergd UK Dementia Research Institute at UCL, London, UK;e Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK;f Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden;g Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden;h Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China;i WI Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USAView further author information

Steve Vucicj Brain and Nerve Research Centre, Concord Hospital, University of Sydney, Sydney, AustraliaView further author information

Matthew C. Kiernana Brain and Mind Centre, Faculty of Medicine and Health, Translational Research Collective University of Sydney and Department of Neurology, Royal Prince Alfred Hospital, Sydney, AustraliaView further author information

Alexander M. Rossorb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information

Julian D. Gillmorec National Amyloidosis Centre, UCL Division of Medicine, Royal Free Hospital, London, UKView further author information

Mary M. Reillyb Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKView further author information

show all

Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice

Supplemental Material

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice

Supplemental Material

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date